VTAK Furnishes Press Release Announcing Q2 and H1 2025 Financial Results

Rhea-AI Filing Summary

Catheter Precision, Inc. furnished a Current Report on Form 8-K to announce that it issued a press release on August 11, 2025 reporting its financial results for the three and six months ended June 30, 2025. The company states the full press release is attached as Exhibit 99.1 and is incorporated by reference into the report. The company also clarifies that the information furnished under Item 2.02, including Exhibit 99.1, is being furnished and not filed for purposes of Section 18 of the Exchange Act and will not be incorporated by reference into future SEC filings unless expressly stated.

Insights

Financial Analyst

TL;DR Routine earnings release furnished; no financial figures provided in the 8-K itself, so investor impact is unclear.

The filing notifies investors that a press release containing Q2 and year-to-date results was issued and attached as Exhibit 99.1. Because the 8-K only furnishes the press release and explicitly states the information is not "filed," the disclosure is procedural rather than providing substantive numbers within the filing. Analysts must review Exhibit 99.1 to assess revenue, profit, cash flow, or changes in guidance. As presented, the 8-K confirms timely disclosure under Item 2.02 but does not by itself change the financial picture.

Corporate Governance Expert

TL;DR The company followed Form 8-K practice by furnishing its earnings press release and clarifying filing status.

The 8-K appropriately identifies the press release as Exhibit 99.1 and states the information is being "furnished" not "filed," limiting legal incorporation into other SEC filings. This is standard practice to provide timely investor communication while managing legal exposure. No governance or compliance issues are apparent from the text provided; however, material content and any forward-looking statements must be reviewed within the attached press release for further assessment.

false 0001716621 0001716621 2025-08-11 2025-08-11

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

___________________

FORM 8-K

___________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

August 11, 2025

___________________

Catheter Precision, Inc.

(Exact name of registrant as specified in its charter)

___________________

Delaware		001-38677		38-3661826
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

1670 Highway 160 West

Suite 205

Fort Mill, SC 29708

(Address of principal executive offices, including zip code)

(973) 691-2000

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report.)

___________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.0001 per share	VTAK	NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On August 11, 2025, Catheter Precision, Inc. (the “Company”) issued a press release announcing its financial results for the three and six months ended June 30, 2025.  The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.  The information in this current report shall not be incorporated by reference into any registration statement or other document filed with the Securities Exchange Commission, whether filed before or after the date hereof regardless of any general incorporation language in any such filing, unless the registrant expressly sets forth in such filing that such information is to be considered “filed” or incorporated by reference therein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit		Description
99.1		Press Release Issued on August 11, 2025
104		Cover Page Interactive Data File (formatted as inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		CATHETER PRECISION, INC.
Date:	August 11, 2025	By:	/s/ Philip Anderson
			Philip Anderson
			Chief Financial Officer

FAQ

What did Catheter Precision (VTAK) disclose in this 8-K?

The company announced it issued a press release on August 11, 2025 reporting financial results for the three and six months ended June 30, 2025, attached as Exhibit 99.1.

Does the 8-K include the actual financial numbers for Q2 2025?

No. The 8-K states a press release was furnished and attached as Exhibit 99.1; the 8-K text itself does not include financial figures.

Is the information in Item 2.02 considered "filed" with the SEC?

No. The company explicitly states the information in Item 2.02 and Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.

Where can investors find the press release referenced in the 8-K?

The press release is attached to the Form 8-K as Exhibit 99.1. Investors should review Exhibit 99.1 for the full results.

Does this 8-K indicate any other material events or transactions?

No. The filing is limited to the furnishing of the earnings press release and does not disclose other material transactions or executive changes.